Thu, January 9, 2025
[ Thu, Jan 09th ] - Kiplinger
The Best Bank ETFs to Buy
Wed, January 8, 2025
Tue, January 7, 2025
Mon, January 6, 2025
Sun, January 5, 2025
Sat, January 4, 2025
Fri, January 3, 2025
[ Fri, Jan 03rd ] - MSN
3 Vanguard ETFs to Buy in 2025
Thu, January 2, 2025
Wed, January 1, 2025
Tue, December 31, 2024
Mon, December 30, 2024
Sun, December 29, 2024
[ Sun, Dec 29th 2024 ] - Forbes
5 Top Index Funds To Buy For 2025
Sat, December 28, 2024
Fri, December 27, 2024
Thu, December 26, 2024
Wed, December 25, 2024
Tue, December 24, 2024

Elon Musk Weighs In on Weight-Loss Drug Stocks. Is LLY or NVO a Better Buy?


//stocks-investing.news-articles.net/content/202 .. loss-drug-stocks-is-lly-or-nvo-a-better-buy.html
Published in Stocks and Investing on Thursday, January 2nd 2025 at 21:01 GMT by MSN   Print publication without navigation

  • Weight-loss drug stocks were catapulted into the spotlight in 2024, creating a lucrative, groundbreaking, and high-stakes industry. Recently, Tesla (TSLA) CEO Elon Musk added to the buzz by sharing his views on weight-loss-focused pharmaceutical companies.

The article discusses Elon Musk's perspective on the investment potential of two pharmaceutical companies, Eli Lilly (LLY) and Novo Nordisk (NVO), which are both involved in the development and marketing of weight loss drugs. Musk, known for his influence in various industries, commented on the stocks during a recent interview, highlighting the growing market for obesity treatments. He did not explicitly endorse one over the other but pointed out the significant market opportunity due to increasing global obesity rates. The article delves into the specifics of each company's offerings, with Eli Lilly's Mounjaro and Novo Nordisk's Wegovy being highlighted as leading treatments. It also covers the financial performance, market share, and future growth prospects of both companies, noting that while both are strong contenders, they face different challenges and opportunities in the competitive landscape of weight loss pharmaceuticals.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/other/elon-musk-weighs-in-on-weight-loss-drug-stocks-is-lly-or-nvo-a-better-buy/ar-AA1wRDm2 ]

Publication Contributing Sources